Described herein are pharmaceutical packaging methods which stop oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive medication, this kind of units which include a syringe with an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with very minimal permeability to